Oncology

Med Health

Promising results in oncology trial for muscle-invasive urothelial carcinoma

Patients facing muscle-invasive urothelial cancer with a high risk of recurrence after surgery might have a promising new treatment option. The Phase III AMBASSADOR (A031501) trial, led by the...

Med Health

CG Oncology, a biotech firm, sees a 96% surge in its debut following an enlarged IPO

This past week saw the pricing of seven Initial Public Offerings (IPOs), with three of them raising more than $100 million each, marking a significant week for the stock...